|
|
Article: e.Lilly Venture Fund Invests in 1747, Inc.; 1747 Introduces Direct-to-Participant Clinical Trials Using the Internet.
- Article from:
- Business Wire
- Article date:
- April 18, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors, Health/Medical and High Tech Writers
BIOWIRE2K
INDIANAPOLIS--(BW HealthWire)--April 18, 2001
Eli Lilly and Company (NYSE:LLY) and 1747, Inc. today announced a strategic relationship to provide clinical trials conducted directly with participants using the Internet. As part of the agreement, e.Lilly has made an undisclosed equity investment in 1747, Inc.
1747 plans to use the investment combined with existing revenue to complete the development of its direct-to-participant clinical trials system. Additionally, the funds will be used to help accelerate and expand commercialization of its system.
"1747's ...